RECITE Trial: Romiplostim for Chemotherapy-Induced Thrombocytopenia 🌶️🌶️
The Bottom Line The Phase 3 RECITE trial demonstrates that in patients with gastrointestinal cancers and persistent chemotherapy-induced thrombocytopenia (CIT),…
The Bottom Line The Phase 3 RECITE trial demonstrates that in patients with gastrointestinal cancers and persistent chemotherapy-induced thrombocytopenia (CIT),…
chriszacht